Resumen de War against ourselves.
The article discusses the problem of antidrug antibodies (ADAs), which attack new medications called biologics that mimic naturally occurring proteins. Biologics are more effective than traditional drugs, but some patients have ADA that react to them as if they were invasive bacteria, blocking its positive effects. The article discusses growing awareness of this phenomenon and efforts to curb it. It mentions studies conducted at Harvard Medical School and Massachusetts Institute of Technology.
